OBJECTIVE: @entity242 ( @entity242 ) are rare, malignant, and aggressive @entity5 of the uterus. In this study the authors aimed to evalu- ate retrospectively the clinical and pathologic features and to investigate the prognostic factors of the U.S. @entity1 who were treated in their department in the last 20 years. MATERIALS AND METHODS: The archive files, medical, and pathological records of the 132 @entity242 @entity1 who were operated on and regularly followed up in the clinic between March 1991-March 2011 were reviewed. Clinical features, operation characteristics, pathological findings, adjuvant therapies, and follow-up data of the @entity1 and their effects on survival were investigated. Analysis of disease-free survival (DFS) and @entity1349 ( @entity1349 ) were calculated using Kaplan-Meier and Cox regression tests. Thep value was taken <0.05 to maintain the statistical significance level for all results. Results: Seventy of the @entity1 were diagnosed with @entity1822 ( @entity1822 ), 33 were with @entity6962 , 12 were with @entity6019 ( @entity6019 ), nine were with undifferentiated @entity1478 , five were with @entity6020 , and three were with botryoid @entity980 . The average @entity1 ' age was 53.7 +/- 12.6 (17-78). About two-thirds of the @entity1 were in postmenopausal and one-third were in pre- menopausal period. @entity3556 was detected as the most common reason for @entity1 ' admission (68.9%). All cases underwent surgery and a procedure of total abdominal hysterectomy + bilateral salpingo-oophorectomy (TAH + BSO) was performed for most of them (88%). The mean duration of follow-up was 36 months (4-198). The two- and five-year @entity1349 rates were 65% and 36%, respectively, with a median time of 37 months (95% CI, 28-45). The two- and five-year DFS rates were 59% and 33%, respectively, with a median time of 29 months (95% CI, 18-40). CONCLUSION: As a result of multivariate analysis, while age, stage, lymphovascular space invasion (LVSI), and lymphadenectomy were found to be independent prognostic factors affecting DFS, only stage was detected as an independent prognostic factor for @entity1349 .

Clinicopathological features and prognostic factors of the uterine XXXX : 20 years of experience at Cukurova University.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3556 :: ('MESH:D014592', 'Disease') :: ['Vaginal bleeding'] @entity242 :: ('MESH:D012509', 'Disease') :: ['US', 'Uterine sarcomas'] @entity6020 :: ('MESH:D018195', 'Disease') :: ['adenosarcomas'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors'] @entity6019 :: ('MESH:D018203', 'Disease') :: ['endometrial stromal sarcomas', 'ESS'] @entity1822 :: ('MESH:D007890', 'Disease') :: ['leiomyosarcomas', 'LMS'] @entity6962 :: ('MESH:D002296', 'Disease') :: ['carcinosarcomas'] @entity1478 :: ('MESH:D014591', 'Disease') :: ['endometrial sarcomas'] @entity980 :: ('MESH:D012208', 'Disease') :: ['rhabdomyosarcomas'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity242 :: (MESH:D012509,Disease) :: ['sarcomas']
